Cutaneous human papillomavirus E6 impairs the cGAS-STING pathway

Grant Brooke1, Dalton Dacus1, Rose Pollina1

  • 1Division of Biology, Kansas State University, Manhattan, Kansas, USA.

Msphere
|February 26, 2026
PubMed

Insights

Beta human papillomaviruses (β-HPVs) can suppress the cGAS-STING innate immune pathway, promoting skin cancer development. This study shows β-HPV 8 E6 impairs this crucial immune response, aiding viral prevalence.

Area of Science:

  • Virology
  • Immunology
  • Oncology

Background:

  • Beta human papillomaviruses (β-HPVs) are linked to skin cancer by destabilizing host genomes.
  • β-HPV 8 E6 expression causes genomic instability, yet paradoxically promotes cell proliferation.
  • The mechanisms by which β-HPVs overcome anti-proliferative signals are not fully understood.

Purpose of the Study:

  • To investigate the hypothesis that β-HPV 8 E6 attenuates the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway.
  • To determine if β-HPV 8 E6 interferes with innate immune responses to cytosolic double-stranded DNA (dsDNA).

Main Methods:

  • Transfection of cells with dsDNA to activate the cGAS-STING pathway.
  • Assessment of β-HPV 8 E6's effect on STING phosphorylation and cGAS-STING pathway activation intensity.
  • Unbiased assessment of β-HPV 8 E6's impact on innate immunity gene expression.

Main Results:

  • β-HPV 8 E6 significantly reduced cGAS-STING pathway activation intensity in response to dsDNA.
  • STING phosphorylation was decreased by β-HPV 8 E6, indicating pathway attenuation.
  • β-HPV 8 E6 broadly downregulated innate immune-associated genes, including interferon-inducible genes.

Conclusions:

  • β-HPV 8 E6 impairs the cGAS-STING innate immune response by reducing STING phosphorylation.
  • This suppression of innate immunity may contribute to β-HPV prevalence and skin cancer development.
  • Both β-HPVs and α-HPVs appear to share a strategy of downregulating innate immune responses.